Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | BMRN BioMarin Pharmaceutical Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $63.94 -1.8% | $15.06 -2.0% |
| StockIQ Score | 59C Moderate Risk: Medium | 36F Weak Risk: Medium |
| Technical | 51C- | 13F |
| Fundamental | 63C+ | 35F |
| Growth | 51C- | 50C- |
| Fair Value | 57C | 38F |
| News | 86A | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 54C- | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
BioMarin (BMRN) outperforms Ascentage Pharma (AAPG) on all measured scores. Its investor, technical, fundamental and valuation scores are in the mid‑50s, compared with AAPG’s 35, 13 and 38 respectively. Even the growth score is higher for BMRN (51 vs 50). Overall, BMRN receives a moderate rating while AAPG is rated weak.